Blog

From Reactive to Strategic: How AI Is Transforming Medical Information Contact Centers

IntroductionFor decades, Medical Information (MI) has been an essential function within pharma, but largely a reactive one. This is especially true in medical information contact centers, which serve as the first line of support for HCPs and patients. When someone has a...
Blog

Is AI Ready to Transform COA Development?

AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover...
Blog

Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them

In a recent "LifeSci Talks" episode, TransPerfect Global Practice Leader Mark Wade and Signant Health VP and eCOA Scientist Bill Byrom PhD discussed how new FDA guidance is reshaping how sponsors approach patient-reported outcomes (PROs) in cancer clinical trials. PROs...
Blog

Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU...
Blog

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages,...
Blog

Why 75% of Medical Device Manufacturers Are Disappointed with Their AI Results

The Gap "The results we're seeing from AI are only as good as the data and structure we put behind it. Most manufacturers haven't done that work yet." — Marc Miller, Division President, TransPerfect Medical DeviceArtificial intelligence has arrived in medical device...
Blog

Metadata In, Metadata Out: Reducing RIM Submission Rework with In-System Translation

Pharmaceutical companies spend billions and take years to bring therapies to market. Then many risk it all on a translation process managed with spreadsheets, email chains, and blind faith. Every label update, every safety amendment, every regulatory change notice must be...
Blog

AI Content Creation and Maintenance in Medical Information: Ending the Content Whack-a-Mole

For many medical information (MI) teams, content maintenance can often feel like a game of whack-a-mole.Update one answer, three more pop up. Fix a regional version, and another channel drifts out of sync. Add a new piece of literature, and suddenly every approved response...
Blog

When Licensing Becomes the Bottleneck: Lessons from a Sponsor on COAs, eCOA Vendors, and Getting It Right

Clinical outcome assessment (COA) licensing has a reputation in the industry, and it's not a flattering one. "It is often called the bottleneck of COA," says Mark Wade, Global Practice Leader and COA SME, in a recent LifeSci Talks episode with Stacey Higgins, who holds...
Blog

Medical Device Localization: Navigating Compliance and Empowering Engagement

As medtech digital health ecosystems expand, companies face growing pressure to deliver products and information tailored to each global market. Meeting that demand requires a strategic approach to medical device translation and localization spanning cultural adaptation,...
Blog

The Role of AI and Machine Learning in Clinical Outcome Assessment Translation

Author: Mark Wade, Global Practice Leader & COA SME, TransPerfect Life SciencesThere is little doubt across the industry that artificial intelligence (AI) and machine learning (ML) have changed the game, particularly when it comes to clinical research. From using it to...
Blog

Why Global Medical Affairs Can’t Ignore Website Localization

A hospital pharmacist in Spain noticed a potential adverse event trend and looks for official guidance on the pharmaceutical product’s website. The safety reporting page exists, but only in English, and with dense regulatory language that’s hard to interpret quickly. The...
Blog

Clinical Trials Translation Management: A Scalable Workflow for Faster Enrollment

When it comes to clinical trials, website localization isn’t just about translating words into other languages. It’s about designing a governed, repeatable workflow that keeps every multilingual page accurate, reviewable, and in sync as content changes. This ensures patients,...
Blog

7 Workflow Hacks for Smarter Clinical Trial Localization

Imagine this: a director of clinical operations at a mid-size pharma needs better regional recruitment to hit aggressive enrollment deadlines. So, they push to launch the company website in nine languages at once. The moment the request lands, the clinical compliance manager...
Blog

Operationalizing AI in Global Pharma Product Launch

AI has moved from a sensitive topic to a standard expectation in pharmaceutical organizations. Leadership teams are asking for it. Departments are experimenting with it. Pilot programs are underway across the enterprise.Yet despite this momentum, most AI initiatives stall...
Blog

Localizing Health Apps at Global Scale: UI/UX Considerations

With 200 new mHealth (mobile health) apps launching daily, it’s safe to say that the digital health market is exploding. For health-tech startups and established organizations looking to scale across global markets, the differentiator in a competitive landscape isn’t always...
Blog

Back to the Basics: Foundations of COA Localization

This blog is a follow-up from our webinar Foundations of Clinical Outcome Assessment Localization.Clinical outcome assessments (COAs) play an increasingly central role in capturing how patients feel, function, and experience their condition or treatment. Yet as studies...
Blog

Immediate Use Cases for GenAI in Pharma

AI’s promise for the life sciences industry is enormous. Equally enormous is the hesitation to leverage it. Many organizations never make it past the pilot (if that), convinced they must solve every data challenge or build complex, validated AI pipelines from the get-go.In...
Blog

From Documents to Data: A New Paradigm for Pharma in the Age of AI

Artificial intelligence has become the buzzword of the decade in life sciences. From discovery to development to regulatory submission, every function is exploring how to embed generative AI into its processes. Yet for most pharmaceutical organizations, a sobering truth...
Blog

Integrating eCOAs and Digital Health for Patient-Centric Trials

A New Era of Patient-First Design Clinical research is undergoing a fundamental transformation as technology takes on a larger role in how trials are designed and executed. This shift is not simply about digitizing paper-based processes, but about creating ecosystems...
Blog

How Digital Innovation is Expanding the Role of Medical Affairs

Redefining the Role of Medical Affairs Medical Affairs has long served as the bridge between clinical development, regulatory functions, and the healthcare providers who ultimately deliver therapies to patients. Today, that role is expanding as digital transformation...
Blog

Redefining the Role of Medical Affairs with Digital Transformation

Redefining the Role of Medical Affairs Medical Affairs has long served as the bridge between clinical development, regulatory functions, and the healthcare providers who ultimately deliver therapies to patients. Today, that role is expanding as digital transformation...
Blog

Transforming Medical Affairs Practices with AI and Automation for Scalable Impact

Integrating Technology to Serve Medical Affairs Teams as an Operational Partner  Medical affairs is entering a new era. With AI and automation, teams can expand their reach, strengthen engagement, and deliver greater value across the organization. These tools do not...
Blog

Generative AI Strategies for Life Sciences: Creating Content that Performs, Complies, and Resonates

Shaping the Conversation Around AI Everywhere you look, people are talking about generative AI. The hype is hard to escape, but in life sciences, the conversation quickly shifts from excitement to hesitation. How do you embrace AI in an industry where compliance, data...
Blog

How Patients Discover Clinical Trial Websites: The Role of Localization in Accessibility

Patient recruitment strategy is becoming faster, broader, and more inclusive than ever. Yet many clinical trial websites still overlook two critical factors that determine whether patients can find and engage with trial opportunities: accessibility and localization. Together,...
Blog

AI-Powered Literature Monitoring for Medical Affairs & Medical Information Teams

Streamline your global literature monitoring activities and facilitate your Medical Affairs workflows and content development with AI-Powered literature monitoringMedical Affairs and Medical Information teams are tasked with staying informed on the latest clinical research,...
Blog

Improving Learning Outcomes in Life Sciences Through Data-Driven Benchmarking

Whether onboarding new commercial staff, refreshing regulatory requirements, or preparing clinical teams for new protocols, the goal of training remains the same: equip people with the knowledge and skills they need to succeed. During our recent webinar, Jessica Peyser,...
Blog

How Patients Discover Clinical Trial Websites: The Role of Localization in Search and Trust

Could localization be the key to improving patient recruitment in clinical trials?Recruiting participants for clinical trials is a critical step in bringing new therapies and treatments to market, but despite advances in digital outreach, the industry still faces major...
Blog

Rewriting the Rules of Informed Consent Development with AI

How AI and Structured Content Management Are Transforming the ICF ProcessInformed consent forms (ICFs) are essential to clinical trials, serving as the primary vehicle for communicating study information to participants in a clear, ethical, and compliant manner. Given...
Transperfect News

Independent Study Documents $2.55M in Savings Generated by TransPerfect’s GlobalLink Technology

<p>A Forrester Consulting study, commissioned by TransPerfect but conducted independently, found that TransPerfect’s GlobalLink® technology suite delivered a net present value of $2.55 million for a global pharmaceutical company by improving translation workflows. The...